“Minimal Residual Disease Elimination by Consolidation Therapy With Alemtuzumab”. Hematology Meeting Reports (formerly Haematologica Reports) 1, no. 2 (May 28, 2009). Accessed June 20, 2025. https://journals.pagepress.org/hmr/article/view/227.